Company news

BetterLife Pharma Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19

May 13, 2020

BetterLife Pharma Confirms Re-Pricing of Warrants

May 12, 2020

BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group

May 11, 2020

BetterLife Pharma Enters into a Licensing Agreement

May 7, 2020

BetterLife Pharma Provides Shareholder Update

April 7, 2020

BetterLife Pharma Acquires Swiss Based Solmic AG with Unique Global Patent for Production of New Generation CBD based Biopharmaceuticals

February 3, 2020

BetterLife Pharma strengthens Board of Directors and Management

January 22, 2020

BetterLife Pharma files site evidence package with Health Canada

January 6, 2020

CSE New Listing - Better Life Pharma Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

December 16, 2019

Pivot Pharmaceuticals re-brands as BetterLife Pharma Inc

December 5, 2019

Pivot Signs Exclusive Manufacturing Agreement with Bio V Pharma Inc.

May 30, 2018

Pivot Pharma Retains Cannabis Compliance to File Dealer's License Application on Behalf of Agro-Biotech Inc.

March 12, 2018

Pivot Pharma Acquires Thrudermic, LLC

March 6, 2018

Pivot Pharma Closes C$5M Private Placement of Convertible Debentures

March 5, 2018

Pivot Pharma Completes Acquisition of California-Based ERS Holdings, LLC

February 27, 2018

Pivot Provides Market Activity Update

February 13, 2018

Pivot Pharmaceuticals Provides Corporate Update

February 12, 2018

Pivot Files Three New Provisional Patents for the Delivery of Cannabinoids

February 1, 2018

Pivot Continues To Build Technology Portfolio

January 17, 2018

Pivot To Initiate Topical Product Development With Israel Based Research Organizations

January 9, 2018

Pivot to Commercialize Cannabis Products in California Under New Regulations

January 3, 2018

CSE New Listing - Pivot Pharmaceuticals Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

December 29, 2017

Pivot Enters Into Standstill Agreement

December 27, 2017

Pivot to Enter Legal Cannabis Markets in U.S.

December 22, 2017

Pivot Pharma Signs Binding Letter of Intent to Acquire Cannabis Oil Infusion Technology for Use in Food and Beverage Products

December 20, 2017

Pivot Pharmaceuticals To Commence Trading on CSE

December 18, 2017

Pivot Pharmaceuticals Receives Conditional Approval for CSE

November 20, 2017

Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board

November 9, 2017

Pivot Pharma and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids

September 25, 2017

Pivot Pharmaceuticals Acquires BiPhasix(TM) Transdermal Drug Delivery Technology

September 12, 2017

Investor Network: Amplify Snack Brands, INC to Host Earnings Call

August 8, 2017

Pivot Pharmaceuticals Files Application for Canadian Stock Exchange (CSE) Listing

July 12, 2017

Pivot Pharmaceuticals Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office

March 30, 2017

Post Earnings Coverage as Amplify Snack's Quarterly Revenue Soared 91%; Adjusted EPS Jumped 44%

March 23, 2017

Pivot Appoints Dr. Pravin Chaturvedi, PhD to Chair Scientific Advisory Board

August 12, 2015

Neurokine Signs Contract with Clinical Investigation Group to Initiate Phase II Clinical Trials

February 8, 2011

Pharmaceutical Company Announces Completion of New Phase II Clinical Trial Plan for Treatment of Alzheimer's

January 28, 2011

Neurokine Pharmaceuticals Completes New Phase II Clinical Trial Plan for Treatment of Alzheimer's

January 26, 2011

← Newer news releases

Decks